Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20593
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dimitriadis, F. | en |
dc.contributor.author | Tsounapi, P. | en |
dc.contributor.author | Saito, M. | en |
dc.contributor.author | Watanabe, T. | en |
dc.contributor.author | Sylakos, A. | en |
dc.contributor.author | Tsabalas, S. | en |
dc.contributor.author | Miyagawa, I. | en |
dc.contributor.author | Sofikitis, N. | en |
dc.date.accessioned | 2015-11-24T19:08:47Z | - |
dc.date.available | 2015-11-24T19:08:47Z | - |
dc.identifier.issn | 1873-4286 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20593 | - |
dc.rights | Default Licence | - |
dc.subject | Acrosome Reaction/drug effects | en |
dc.subject | Cyclic GMP/metabolism | en |
dc.subject | Cyclic Nucleotide Phosphodiesterases, Type 5/biosynthesis | en |
dc.subject | Epididymis/*physiopathology | en |
dc.subject | Genital Diseases, Male/*complications/*drug therapy/physiopathology | en |
dc.subject | Genitalia, Male/metabolism | en |
dc.subject | Humans | en |
dc.subject | Infertility, Male/*drug therapy/enzymology/*etiology | en |
dc.subject | Leydig Cells/metabolism | en |
dc.subject | Male | en |
dc.subject | *Phosphodiesterase 5 Inhibitors | en |
dc.subject | Phosphodiesterase Inhibitors/*therapeutic use | en |
dc.subject | Semen/cytology/drug effects | en |
dc.subject | Seminiferous Tubules/metabolism | en |
dc.subject | Sertoli Cells/metabolism | en |
dc.subject | Sperm Capacitation/drug effects | en |
dc.subject | Spermatozoa/drug effects | en |
dc.subject | Testicular Diseases/*complications/*drug therapy | en |
dc.title | Is there a role for PDE5 inhibitors in the management of male infertility due to defects in testicular or epididymal function? | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19860697 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2009 | - |
heal.abstract | This review study refers to the possibility to employ PDE5 inhibitors as an adjunct tool for the therapeutic management of male infertility. The literature tends to suggest that PDE5 inhibitors enhance the Leydig cell secretory function and play a role in the regulation of the contractility of the tunica albuginea and the epididymis. In addition, the literature suggests that PDE5 inhibitors increase the prostatic secretory function that results in an improvement in sperm motility in several cases. Some studies additionally demonstrate a role of PDE5 inhibitors in the regulation of sperm capacitation process. Additional placebo-controlled, randomized, blind studies are necessary to unequivocally suggest a therapeutic role of PDE5 inhibitors in the alleviation of semen disorders and male infertility. | en |
heal.journalName | Curr Pharm Des | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License